SCYNEXIS
SCYX
#10067
Rank
ยฃ20.65 M
Marketcap
ยฃ0.49
Share price
-2.00%
Change (1 day)
-47.67%
Change (1 year)

Revenue for SCYNEXIS (SCYX)

Revenue in 2025 (TTM): ยฃ2.21 Million

According to SCYNEXIS's latest financial reports the company's current revenue (TTM ) is ยฃ2.2 Million. In 2024 the company made a revenue of ยฃ2.98 Million a decrease over the revenue in the year 2023 that were of ยฃ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SCYNEXIS from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ2.21 M-25.65%
2024 ยฃ2.98 M-97.29%
2023 ยฃ0.11 B2514.02%
2022 ยฃ4.2 M-56.85%
2021 ยฃ9.75 M
2020 N/A-100%
2019 ยฃ0.09 M-54.25%
2018 ยฃ0.2 M6.47%
2017 ยฃ0.18 M-8.7%
2016 ยฃ0.2 M19.63%
2015 ยฃ0.17 M-97.33%
2014 ยฃ6.5 M-36.34%
2013 ยฃ10.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Galmed Pharmaceuticals
GLMD
N/AN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
KemPharm
KMPH
ยฃ7.85 M 256.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
ยฃ3.31 B 150,718.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.43 B 19,620.19%๐Ÿ‡บ๐Ÿ‡ธ USA